Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications
Read more>

Lubris Biopharma announces outlicensing of its proprietary recombinant human lubricin for us in opthalmology to major pharma company.
Read more>

Lubris Biopharma announces positive results of a clinical trial demonstrating significant improvement in both signs and symptoms of dry eye disease.
Results are published in the September issue of The Ocular Surface.

Lubris BioPharma CEO receives Biocom Life Science Catalyst Award
Learn more >

Discovery of ‘Mother Nature’s lubricant’ leads biomedical researcher to explore new health applications
Learn more >

New research shows potential role of lubricin in reducing inflammation in osteoarthritis.
Ann Phys Rehabil Med. 2016 Jun;59(3):149-56
Sci Rep. 2016 Jan 11;6:18910

Lubricin binding to CD44: a new mechanism supporting lubricin’s integral role in joint health.
Arthritis Rheumatol. 2015 Jun;67(6):1503-13.

Rheumatoid arthritis and osteoarthritis patients have significantly reduced levels of synovial lubricin.
PLoS One. 2015 May 1;10(5):e0125192

Treatment with recombinant lubricin shows efficacy in hormone induced osteoarthritis.
Bone. 2015 May;74:37-47

Moderate exercise is good for your joints: increased lubricin expression and improved cartilage health!
Scand J Med Sci Sports. 2015 Apr;25(2):e222-30

Loss of lubricin following ACL injury liked with development of post-traumatic osteoarthritis
Biomed Rep. 2015 Mar; 3(2): 147–151.

Dr. Greg Jay publishes lubricin review article in the Journal Matrix Biology.
Matrix Biol. 2014 Oct;39:17-24

Radio Canada Interview with Dr. Tannin Schmidt.

New Discoveries Hold Promise for a Range of Women’s Health Issues.
Mass Eye & Ear Institute

“Role of lubricin in the prevention of chondrocyte apoptosis” published in the Proceedings of the National Academy of Sciences.

“Could lubricin stop OA in damaged joints?” an Interview with Dr. Greg Jay.
Brown University Press

“Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface,” published in the Journal of the American Medical Association.
JAMA Ophthalmol. 2013 Jun;131(6):766-76